Sljedeći

Auto Play

Dr. Jonathan Trent on FDA Approval of Trabectedin for Soft Tissue Sarcomas

14 Pogledi • 07/18/23
Udio
Ugraditi
administrator
administrator
Pretplatnici
0

Jonathan C. Trent, MD, professor of Medicine, co-director, Musculoskeletal Center, Sarcoma Medical Research Program, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, discusses the FDA approval of trabectedin for patients with soft tissue sarcomas.

Prikaži više
0 Komentari sort Poredaj po
Komentari na Facebooku

Sljedeći

Auto Play